Institute of Systems Molecular and Integrative Biology

Three Liverpool professors make top 100 ‘Power List’ of analytical scientists

October 15, 2021

AGILE COVID-19 drug testing platform opens new trial in South Africa

October 7, 2021

Study identifies sulfatase which could be a potential drug target for inflammatory bowel disease and colorectal cancer

October 6, 2021

Inhibiting targets of SARS-CoV-2 proteases can block infection, study shows

September 21, 2021

Liverpool announces world leading ‘end-to-end’ Pandemic Institute

September 13, 2021

Epilepsy surgery may improve overall brain health, study finds

August 10, 2021

Frequent consumption of peanuts by cancer patients may increase risk of cancer spread

August 4, 2021

COVID: Risks of severe illness in children shown to be very low in largest study yet

July 9, 2021

University teams up with BARD1 Life Sciences Ltd for type 3C diabetes test

July 5, 2021

Liverpool team recruits first UK patient for personalised ‘therapeutic cancer vaccine’ trial

June 28, 2021